FDA WARNING_LETTER - snushaven.com - February 01, 2026

The U.S. Food and Drug Administration (FDA) issued a Warning Letter to snushaven.com on February 27, 2026, after reviewing its website and finding that nicotine pouch products were offered for sale to U.S. consumers. The primary violation identified was the unlawful sale of a tobacco product to an individual under 21 years of age. Specifically, during an FDA investigation, snushaven.com sold "Zyn - Apple Mint Mini (6mg)" nicotine pouches to a minor. This action renders the product "misbranded" under section 903(a)(7)(B) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), violating section 906(d)(5) which prohibits retailers from selling tobacco products to persons under 21. Nicotine pouch products fall under FDA jurisdiction as tobacco products per section 201(rr) of the FD&C Act. snushaven.com is required to promptly address these violations and ensure all its products, labeling, and advertising comply with the FD&C Act and FDA regulations. A written response detailing corrective actions and a compliance plan must be submitted within 15 working days. Failure to comply may lead to regulatory actions such as civil money penalties, product seizure, or injunction.